A single center study to evaluate the long term outcomes with alemtuzumab induction therapy in renal transplant recipients.
Phase of Trial: Phase II
Latest Information Update: 20 Aug 2015
At a glance
- Drugs Alemtuzumab (Primary) ; Methylprednisolone; Mycophenolate mofetil; Tacrolimus
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 20 Aug 2015 New trial record